Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Inductive Bio on a Winning Streak With ADMET Predictions

    Apr 2, 2026, 01:01 AM by User Not Found
    Bio-IT World | Following on the heels of a similar victory in 2025, Inductive Bio earlier this year took home gold in an all-comers prediction competition focused on the properties of chemical compounds critical to drug development. In the latest OpenADMET-ExpansionRx blind challenge, Inductive Bio placed first among more than 370 submissions in what has become the “Olympics of ADMET prediction."
    Full story
  • LabConnect Launches SampleGISTICS® 2.0 to Digitize Clinical Trial Sample Capture

    Apr 1, 2026, 08:17 AM by
    LabConnect has launched SampleGISTICS 2.0, a mobile application designed to replace legacy digital pen technology and paper-based requisitions with a smartphone-based workflow. The platform enables clinical research sites to scan and transmit sample data in real time, providing immediate visibility into sample location and stability from the point of collection through laboratory intake. This digitization aims to reduce manual data entry errors and streamline logistics for global decentralized clinical trials.
    Full story
  • Ansa Biotechnologies Appoints Matthias Arenskötter as Chief Operating Officer

    Apr 1, 2026, 08:17 AM by
    Ansa Biotechnologies appointed Matthias Arenskötter, PhD, as chief operating officer. Dr. Arenskötter will lead global operations, including manufacturing, supply chain, and quality systems, as the company scales to meet rapidly rising demand for its groundbreaking synthetic DNA products.
    Full story
  • Symbiosis Expands Commercial Capabilities with Addition of New Stability Chamber

    Apr 1, 2026, 08:17 AM by
    Full story
  • From Data to Discovery: Inside the Bio-IT Hackathon

    Apr 1, 2026, 01:01 AM by User Not Found
    Bio-IT World | t a time when research is generating more data than ever before, a growing question looms: how do scientists actually make use of it? At the Bio-IT World Hackathon, organizers believe that the answer lies not just in better tools, but in better collaboration—and increasingly, in the intelligent use of AI. Allissa Dillman, founder and CEO of BioData Sage, and LaFrancis Gibson, manager for health promotion at ORAU, h join the newest episode of Trends from the Trenches with host Allison Proffitt to discuss how the Hackathon brings together a diverse mix of participants to work intensively on real-world biomedical data challenges.
    Full story
  • From Data to Discovery: Inside the Bio-IT Hackathon

    Apr 1, 2026, 01:00 AM by User Not Found
    Bio-IT World | At a time when research is generating more data than ever before, a growing question looms: how do scientists actually make use of it? At the Bio-IT World Hackathon, organizers believe that the answer lies not just in better tools, but in better collaboration—and increasingly, in the intelligent use of AI. Allissa Dillman, founder and CEO of BioData Sage, and LaFrancis Gibson, manager for health promotion at ORAU, h join the newest episode of Trends from the Trenches with host Allison Proffitt to discuss how the Hackathon brings together a diverse mix of participants to work intensively on real-world biomedical data challenges.
    Full story
  • Symeres and Ambagon Therapeutics collaborate on molecular glue research in colorectal cancer

    Mar 31, 2026, 08:15 AM by
    Full story
  • Mymezage Technologies Emerges as a Leading Software Company in Nagercoil Offering Smart Business Solutions

    Mar 31, 2026, 08:15 AM by
    Mymezage Technologies, a leading software company in Nagercoil, offers billing software, web development, and digital marketing services. Their solutions help businesses improve efficiency, automate operations, and achieve digital growth.
    Full story
  • CD Genomics Highlights RNA Sequencing Services for Transcript Discovery and Isoform-Level Research

    Mar 30, 2026, 08:12 AM by
    Full story
  • Canada Launches National AI Initiative to Solve Bottleneck in Genomic Medicine

    Mar 30, 2026, 08:12 AM by
    PhenoTips and five leading health institutions form the CIPHER network, backed by $5.4 million through Genome Canada, to build the infrastructure precision medicine needs to scale.
    Full story
  • Mapping the Trillion-Gene Universe: The Startup That Wants to Teach AI the Language of Life

    Mar 30, 2026, 01:00 AM by User Not Found
    Bio-IT World | Basecamp Research, the AI-biology lab, has announced the Trillion Gene Atlas: a plan to collect genomic data from more than 100 million species across 31 countries, expand the known genetic universe by a factor of 100, and compress what it estimates would be 20 years of data processing into under two years.
    Full story
  • Lonza Launches Media Development Lab in Singapore for Cell Culture Media Optimization

    Mar 27, 2026, 08:22 AM by
    Lonza has announced the launch of its Media Development Lab at its Singapore site.
    Full story
  • Creative Proteomics Strengthens Protein Dynamics and Interaction Research Support With HDX-MS

    Mar 27, 2026, 08:22 AM by
    Creative Proteomics has launched a dedicated HDX-MS service to help researchers study protein higher-order structure, conformational dynamics, and molecular interactions under solution-phase conditions. The offering supports applications such as epitope mapping, ligand binding analysis, comparability assessment, and formulation stability studies, with end-to-end support from study design through data interpretation. Intended for research use only, the service is designed to deliver practical, decision-ready insight into protein structural change, solvent accessibility, and interaction behavior.
    Full story
  • The Value of Prediction, and Cost of Success, in Drug Hunting

    Mar 26, 2026, 01:00 AM by User Not Found
    Bio-IT World | Across the pharmaceutical industry, generative artificial intelligence is now running an estimated 10 to 20 million predictions a day in a quest to accelerate drug discovery by exploring new molecules and chemical reactions at an unprecedented pace. Access to hardware determines AI capabilities, but the tech-driven process of making medicines is still “done by people for people,” with a human in the loop calling the shots and running the machinery.
    Full story
  • eClinical Solutions elluminate® Platform Supports argenx to Enhance Data Oversight and Efficiency

    Mar 25, 2026, 08:19 AM by
    Innovation allows for real-time data and operational insights to advance immunology breakthroughs
    Full story
  • Phenomix Sciences Report Finds Patients See GLP-1s as Progress, Not a Cure; Want More Guidance on Long-Term Care

    Mar 25, 2026, 08:19 AM by
    National survey shows patient expectations and perceptions of GLP-1s are evolving, and clearer education is shaping obesity treatment decisions.
    Full story
  • Optibrium Introduces Graphical Interface for QuanSA to Enhance Ligand-Based Affinity Predictions

    Mar 25, 2026, 08:19 AM by
    New user interface provides visual insights to guide compound optimisation
    Full story
  • iXCells Biotechnologies Joins International Collaboration to Evaluate Chemotherapeutic Toxicity in Human Organoids

    Mar 25, 2026, 08:19 AM by
    Full story
  • Kindeva® commemorates 70 years of the pMDI as inventors are inducted into the ‘National Inventors Hall of Fame’

    Mar 25, 2026, 08:19 AM by
    Full story
  • Sygnature Discovery strengthens in vivo pharmacology leadership with appointment of Susanne Back

    Mar 25, 2026, 08:19 AM by
    Full story
  • 1 (current)
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy